Stavudine Main Page

Medical Advocates
Stavudine (Zerit)

Main Page

New and Noteworthy

Drug Alert
Guidelines
Database of ARV Drug Interactions
Journal Data
Conference Data
Perinatal Data
Pediatric Data
Nucleoside Reverse Transcriptase Inhibitor Data

ARV Drugs Main Page Main New/Newsworthy Home Page

This web page is best viewed by using INTERNET EXPLORER
Last Update: August 04, 2008
Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader

New and Noteworthy

July 2008

A WEEK IN REVIEW FEATURED REPORT
Viral efficacy maintained and safety parameters improved with a reduced dose of stavudine: a pilot study.
Ait-Mohand H, Bonmarchand M, Guiguet M, et al HIV Med. 2008 Jul 21.

June 2008

Fanconi syndrome and lactic acidosis associated with stavudine and lamivudine therapy.
Nelson M, Azwa A, Sokwala A, et al AIDS. 2008 Jul 11;22(11):1374-6.

Randomization to once-daily Stavudine extended release/lamivudine/efavirenz versus a more frequent regimen improves
adherence while maintaining viral suppression.
Boyle BA, Jayaweera D, Witt MD, et al HIV Clin Trials. 2008 May-Jun;9(3):164-76.

Long-term subcutaneous tissue changes among antiretroviral-naive persons initiating stavudine, zidovudine,
or abacavir with lamivudine.
Shlay JC, Sharma S, Peng G, et al J Acquir Immune Defic Syndr. 2008 May 1;48(1):53-62.

Drug Alerts

Potential for Lactic Acidosis with Zerit
March 29, 2002
BMS Drug Alert

ARV Drugs Main Page

Main New/Newsworthy

Home Page

Stavudine Main Page